Medicare expands obesity treatment access for 27 million seniors
H.R. 4231 — Treat and Reduce Obesity Act of 2025 · Filed by Mike Kelly (R-PA) · 85 cosponsors · Introduced Jun 27, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill expands Medicare coverage for obesity treatment by allowing a broader range of health care providers—including physician assistants, nurse practitioners, dietitians, clinical psychologists, and community-based lifestyle programs—to deliver intensive behavioral therapy for obesity, and requires Medicare Part D drug plans to cover FDA-approved obesity medications (like GLP-1 agonists) starting two years after enactment. The bill aims to reduce the $50 billion annual Medicare spending on obesity-related care by making treatment more accessible and comprehensive.
Why we flagged it
The bill's core mechanism is expanding Medicare coverage for obesity treatment—a public health intervention addressing a documented epidemic. While pharmaceutical companies manufacturing obesity medications stand to benefit financially, the primary driver is broadening access to care for seniors, not creating a private carve-out.
What the text implies
- Obesity medication coverage begins 2 years post-enactment, creating a lag during which pharmaceutical manufacturers may anticipate demand surge and adjust production/pricing strategies.
- Expansion of non-physician providers (PAs, NPs, dietitians, psychologists) may shift treatment delivery away from primary care physicians, potentially fragmenting care coordination despite the bill's coordination language.
The full analysis lists 5 implications of this text.
Who stands to gain
Pharmaceutical manufacturers (obesity medications: GLP-1 agonists, others); Physician assistants, nurse practitioners, clinical psychologists, registered dietitians (expanded b; Community-based lifestyle counseling programs (newly eligible for Medicare reimbursement)